Venture capitalist-backed allergy platforms are pitching personalized immunotherapy delivered conveniently through telehealth.

But allergy care isn’t an algorithm, so when it comes to diagnostic insight, individualized care, and patient relationships, they simply can’t compete with you.

This new patient resource helps you educate patients about allergy options, their costs, and their benefits (or side effects).